Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Published in: Clinical and Experimental Nephrology 1/2008

01-02-2008 | Case Report

Lupus vulgaris with tubercular lymphadenitis and IgA nephropathy

Authors: Ambar Khaira, Om P. Rathi, Sandeep Mahajan, Alok Sharma, Amit K. Dinda, Suresh C. Tiwari

Published in: Clinical and Experimental Nephrology | Issue 1/2008

Login to get access

Abstract

A 14-year-old girl presented with a 10-year history of a large crusted plaque over the right thigh for 10 years and small reddish plaque over the left upper back for 3 months. On routine evaluation, she was found to have hematuria. Skin biopsy from the lesion was suggestive of skin tuberculosis (lupus vulgaris), and kidney biopsy showed features of IgA nephropathy (IgAN). Fine-needle aspiration from the inguinal lymph node was consistent with granulomatous disease. The patient has been on anti-tubercular treatment, and the hematuria has subsided.
Literature
1.
Berger J. IgA glomerular deposits in renal disease. Transplant Proc. 1969;1:939–44.PubMed
2.
Farina C, Gegundez I, Pique E, Esteban J, Martin L, Requena L, Barat A, Guerrero MF. Cutaneous tuberculosis: a clinical, histopathologic, and bacteriologic study. J Am Acad Dermatol. 1995;33:433–40.CrossRefPubMed
3.
Keven K, Ulger FA, Öztas E, Ergün I, Ekmekçi Y, Ensari A, Ates K. A case of pulmonary tuberculosis associated with IgA nephropathy. Int J Tuberc Lung Dis. 2004 8(10):1274–6.PubMed
4.
Cohen AJ, Rosenstein ED. IgA nephropathy associated with disseminated tuberculosis. Arch Intern Med. 1985;145:554–6.CrossRefPubMed
5.
De Siati L, Paroli M, Ferri C, Muda AO, Bruno G, Barnaba V. Immunoglobulin A nephropathy complicating pulmonary tuberculosis. Ann Diagn Pathol. 1999;3:300–3.CrossRefPubMed
6.
Matsuzawa N, Nakabayashi K, Nagasawa T, Nakamoto Y. Nephrotic IgA nephropathy associated with disseminated tuberculosis. Clin Nephrol. 2002;57:63–8.CrossRefPubMed
7.
Pandhi RK, Bedi TR, Kanwar AJ, Bhutani LK. Cutaneous tuberculosis—a clinical and investigative study. Indian J Dermatol. 1977;22:99–107.PubMed
8.
Alifano M, Sofia M, Mormile M, et al. IgA immune response against the mycobacterial antigen A60 in patients with active pulmonary tuberculosis. Respiration. 1996;63:292–7.CrossRefPubMed
9.
May JJ, Katilus J, Henson PM, et al. The purification and identification of circulating immune complexes in tuberculosis. Ann Rev Respir Dis. 1983;128:920–5.
10.
Margall N, Baselga E, Coll P, Barnadas MA, de Moragas JM, Prats G. Detection of Mycobacterium tuberculosis complex DNA by the polymerase chain reaction for rapid diagnosis of cutaneous tuberculosis. Br J Dermatol. 1996;135:231–6.CrossRefPubMed
Metadata
Title
Lupus vulgaris with tubercular lymphadenitis and IgA nephropathy
Authors
Ambar Khaira
Om P. Rathi
Sandeep Mahajan
Alok Sharma
Amit K. Dinda
Suresh C. Tiwari
Publication date
01-02-2008
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2008
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-007-0006-5

Other articles of this Issue 1/2008

Clinical and Experimental Nephrology 1/2008 Go to the issue

Original Article

Dual blockade of the rennin–angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis

Case Report

Nephronophthisis complicated with hepatic fibrosis: an autopsy case with rupture of the splenic artery after renal transplantation

Original Article

Serum adiponectin and markers of endothelial injury in hemodialysis patients with arteriosclerosis obliterans

Review Article

Applications of LDL-apheresis in nephrology

Special Commentary

The Third World Kidney Day: looking back and thinking forward

Review Article

Chronic kidney disease perspectives in Japan and the importance of urinalysis screening
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits